title: Effects of two new pirenzepine analogs on the contractile response of the guinea-pig oesophageal muscularis mucosae to acetylcholine, bethanechol, histamine and high potassium.
abstract: The guinea-pig oesophageal muscularis mucosae was used to determine the affinity for muscarinic receptors of two new tricyclic compounds, DF 545 and DF 594, which are structurally related to pirenzepine. Both acetylcholine and bethanechol induced a concentration-dependent contraction of the muscularis mucosae. This contraction was competitively antagonized by DF 545 and DF 594 over the dose range 10(-7)-10(-5) M, while at higher concentrations both antagonists caused a depression of the maximal response to the cholinomimetics. The potency of DF 545 and DF 594 appeared to be comparable to that of pirenzepine and approximately 50 times lower than that of atropine. By comparing the affinities of DF 545 and DF 594 with those of selective antagonists (methoctramine and 4-DAMP) which discriminate between M2/M3 muscarinic receptor subtypes, it emerged that pirenzepine as well as DF 545 and DF 594 might act on M3 receptors, which seem to be predominant in the guinea-pig oesophageal muscularis mucosae. McN-A-343 exhibited no agonist activity while it acted as a competitive antagonist against acetylcholine and bethanechol. None of the compounds exhibited calcium antagonist properties. DF 545 inhibited the contractile responses to histamine, but DF 594 and pirenzepine did not.
authors.affiliation: Institute of Pharmacology and Pharmacognosy, University of Parma, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Barocelli
authors.forename: G
authors.initials: G
authors.lastname: Morini
authors.forename: V
authors.initials: V
authors.lastname: Ballabeni
authors.forename: A
authors.initials: A
authors.lastname: Lavezzo
authors.forename: M
authors.initials: M
authors.lastname: Impicciatore
mesh_terms: D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology*; D018723:Bethanechol; D001626:Bethanechol Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004947:Esophagus / Q000187:drug effects / Q000502:physiology*; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006633:Histamine Antagonists; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D010880:Piperidines / Q000494:pharmacology; D010890:Pirenzepine / Q000494:pharmacology; D011188:Potassium / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011738:Pyrilamine / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000187:drug effects*
chemical_list: D001570:Benzodiazepinones; D001626:Bethanechol Compounds; D006633:Histamine Antagonists; D010880:Piperidines; D011976:Receptors, Muscarinic; D018723:Bethanechol; C061591:DF 594; D010890:Pirenzepine; D001285:Atropine; C042375:4-diphenylacetoxy-1,1-dimethylpiperidinium; D006632:Histamine; C064721:nuvenzepine; D011738:Pyrilamine; D000109:Acetylcholine; D011188:Potassium